CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
113 hedge funds and large institutions have $75.4M invested in Clovis Oncology, Inc. in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 52 reducing their positions, and 47 closing their positions.
Holders
113
Holders Change
-38
Holders Change %
-25.17%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
20
Reduced
52
Closed
47
Calls
$12.2M
Puts
$9.84M
Net Calls
+$2.41M
Net Calls Change
+$1.11M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$9.72M |
| 2 |
QF
2
QVT Financial
New York
|
$3.78M |
| 3 |
3
Renaissance Technologies
New York
|
$4.12M |
| 4 |
E
4
Ergoteles
New York
|
$1.27M |
| 5 |
CM
5
Caption Management
Oklahoma City,
Oklahoma
|
$328K |
Top Sellers
| 1 |
1
Nuveen Asset Management
Chicago,
Illinois
|
$0 |
| 2 |
2
BlackRock
New York
|
$8.5M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.09M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$20.2M |
| 5 |
HF
5
HRT Financial
New York
|
$235K |
